Transcriptome Analysis Reveals the Potential Mechanism of MAP34-B Targeting Pasteurella multocida

TL;DR

This study uses transcriptome analysis to reveal how the antimicrobial peptide MAP34-B kills the bacteria Pasteurella multocida.

Contribution

The study identifies specific genes and pathways affected by MAP34-B in Pasteurella multocida, revealing its antibacterial mechanism.

Findings

MAP34-B treatment altered 281 genes in Pasteurella multocida, including those involved in ribosome function.

Gene expression changes suggest disruption of bacterial membrane integrity and protein synthesis.

Upregulated ribosomal genes and membrane-associated genes indicate key targets of MAP34-B.

Abstract

Pasteurella multocida is a widespread zoonotic pathogen responsible for substantial economic losses in the poultry industry. The antimicrobial peptide MAP34-B has been shown to exhibit potent antibacterial activity against Pasteurella multocida, while the mechanism of action remains unclear. To elucidate the antibacterial mechanism of MAP34-B, we performed transcriptomic profiling via RNA sequencing (RNA-seq) on clinical strain HB03 treated with or without 47.4 µM MAP34-B for one hour. The results showed that, after treatment with MAP34-B, 281 differentially expressed genes were identified, including 161 upregulated genes and 120 downregulated genes. KEGG pathway enrichment analysis revealed that the Ribosome pathway had the highest proportion of affected genes. After treatment with MAP34-B, the gene expressions of rps2, rps3, rps9, rps16, rpl3, rpl9, rpl22, and rpl23 were upregulated, which may affect bacterial protein synthesis. Additionally, the expression levels of membrane-associated genes, such as SecE, SecG, lolB, and ompR, were also altered, indicating disruption of bacterial membrane integrity. Thus, the antibacterial activity of MAP34-B against Pasteurella multocida primarily involves impairment of cell membrane integrity and inhibition of protein synthesis, providing a theoretical foundation for its potential application in treating bacterial infections.

Figures